Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management
Open Access
- 23 December 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Hereditary Cancer in Clinical Practice
- Vol. 7 (1), 17-7
- https://doi.org/10.1186/1897-4287-7-17
Abstract
Lynch syndrome (LS) is associated with a high risk for colorectal cancer (CRC) and extracolonic malignancies, such as endometrial carcinoma (EC). The risk is dependent of the affected mismatch repair gene. The aim of the present study was to calculate the cumulative risk of LS related cancers in proven MLH1, MSH2 and MSH6 mutation carriers. The studypopulation consisted out of 67 proven LS families. Clinical information including mutation status and tumour diagnosis was collected. Cumulative risks were calculated and compared using Kaplan Meier survival analysis. MSH6 mutation carriers, both males and females had the lowest risk for developing CRC at age 70 years, 54% and 30% respectively and the age of onset was delayed by 3-5 years in males. With respect to endometrial carcinoma, female MSH6 mutation carriers had the highest risk at age 70 years (61%) compared to MLH1 (25%) and MSH2 (49%). Also, the age of EC onset was delayed by 5-10 years in comparison with MLH1 and MSH2. Although the cumulative lifetime risk of LS related cancer is similar, MLH1, MSH2 and MSH6 mutations seem to cause distinguishable cancer risk profiles. Female MSH6 mutation carriers have a lower CRC risk and a higher risk for developing endometrial carcinoma. As a consequence, surveillance colonoscopy starting at age 30 years instead of 20-25 years is more suitable. Also, prophylactic hysterectomy may be more indicated in female MSH6 mutation carriers compared to MLH1 and MSH2 mutation carriers.Keywords
This publication has 31 references indexed in Scilit:
- The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndromeInternational Journal of Cancer, 2008
- Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea.2000
- Cancer risk in mutation carriers of DNA-mismatch-repair genesInternational Journal of Cancer, 1999
- Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinomaCancer, 1998
- Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the DiseaseNew England Journal of Medicine, 1998
- Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancerNature Genetics, 1997
- Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysisGastroenterology, 1996
- Mutations of two P/WS homologues in hereditary nonpolyposis colon cancerNature, 1994
- Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancerNature, 1994
- The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancerCell, 1993